The cucumber gin cooler
WEGOVY is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm
## Availability Status: March 2026 - **FDA status:** Phase 3 clinical trials ongoing - **Expected approval timeline:** Potentially 2026-2027 - **Brand availability:** None yet - **Current access:** Compounding pharmacies (503A/503B) with valid prescription For a detailed breakdown of [retatrutide's FDA approval status and projected timeline](/guides/retatrutide-fda-approval-2026-timeline-status), see our dedicated tracker the date brand pricing becomes available depends directly on when retatrutide clears FDA review
FUENTE: Annals of Internal Medicine, 31 de marzo de 2025 PUBLICIDAD PUBLICIDAD
The FDA approved Wegovy in 2024 to reduce cardiovascular death, heart attack, and stroke risk in adults with established cardiovascular disease and obesity
However, we always found only a partial alignment, which corroborates the concept that eosinophils adapt to their specific niche of residence by transcriptional maturation in response to microenvironmental cues
